GCM
CTRE icon

Genus Capital Management’s CareTrust REIT CTRE Stock Holding History

Genus Capital Management’s Portfolio CTRE Stock Details CTRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.06M Buy
+51,100
New +$2.01M 0.2% 121

Other funds holding CTRE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Cohen & Steers
Cohen & Steers New York $63.2B AUM 17.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Genus Capital Management's CTRE Position: Q2 2026 in Review

Genus Capital Management opened a new position in CareTrust REIT (CTRE) in Q2 2026: 51,100 shares worth $2.06M. The stake represents 0.2% of the portfolio and ranks #121 among its holdings.

512 funds tracked by Wall St. Rank hold CTRE as of Q2 2026.

  • Genus Capital Management held 51,100 shares of CareTrust REIT worth $2.06M as of Q2 2026.
  • CareTrust REIT was a new Genus Capital Management position in Q2 2026.
  • CareTrust REIT made up 0.2% of Genus Capital Management's portfolio in Q2 2026, its #121 holding.
  • 512 funds tracked by Wall St. Rank held CareTrust REIT as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.